The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells.

Saved in:
Bibliographic Details
Title: The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells.
Authors: Hermann TW; Department of Molecular Oncology, Ligand Pharmaceuticals Inc., 10275 Science Center Drive, San Diego, CA 92121, USA., Yen WC, Tooker P, Fan B, Roegner K, Negro-Vilar A, Lamph WW, Bissonnette RP
Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2005 Oct; Vol. 50 (1), pp. 9-18.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print Cited Medium: Print ISSN: 0169-5002 (Print) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0169-5002
DOI:10.1016/j.lungcan.2005.05.008